Profile data is unavailable for this security.
About the company
Sunshine Guojian Pharmaceutical Shanghai Co Ltd is a China-based company mainly engaged in the research and development, industrialization and commercialization of antibody drugs. Its products are mainly used to treat major diseases such as autoimmune diseases and tumors. The Company’s product, recombinant human type II tumor necrosis factor receptor-antibody fusion protein (trade name: YISAIPU), is a fully human antibody drug used to treat rheumatoid arthritis, ankylosing spondylitis and psoriasis. The Company mainly conducts its businesses in Mainland China.
- Revenue in CNY (TTM)1.07bn
- Net income in CNY352.22m
- Incorporated2002
- Employees965.00
- LocationSunshine Guojian Pharmaceutical Shanghai Co LtdChina (Shanghai) Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
- Phone+86 2 180297676
- Fax+86 2 180297676
- Websitehttps://www.3s-guojian.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayinglong Pharmaceutical Group Co Ltd | 3.26bn | 453.31m | 12.25bn | 2.88k | 27.02 | 3.13 | -- | 3.76 | 1.05 | 1.05 | 7.56 | 9.08 | 0.6482 | 5.87 | 11.13 | 1,130,851.00 | 9.26 | 10.82 | 11.03 | 13.47 | 42.87 | 41.18 | 14.29 | 14.08 | 5.18 | -- | 0.0729 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Mabwell Shanghai Bioscience Co Ltd | 191.35m | -1.02bn | 12.76bn | 1.49k | -- | 5.30 | -- | 66.66 | -2.55 | -2.55 | 0.4789 | 6.02 | 0.0412 | 0.0472 | 16.79 | 128,337.60 | -22.02 | -37.61 | -26.37 | -45.95 | 96.84 | 81.54 | -534.78 | -2,112.26 | 1.96 | -- | 0.442 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
| Changchun BCHT Biotechnology Co | 1.92bn | 543.19m | 12.99bn | 1.24k | 23.87 | 3.18 | -- | 6.78 | 1.32 | 1.32 | 4.64 | 9.88 | 0.4116 | 0.8459 | 1.55 | 1,543,550.00 | 11.67 | 9.95 | 14.14 | 12.81 | 89.90 | 86.63 | 28.36 | 24.03 | 2.03 | -- | 0.0158 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.18bn | 208.25m | 13.09bn | 1.55k | 62.86 | 5.82 | -- | 11.08 | 0.9769 | 0.9769 | 5.54 | 10.55 | 0.3743 | 1.21 | 4.71 | 764,598.40 | 6.69 | 5.86 | 9.15 | 7.59 | 63.15 | 55.41 | 17.87 | 17.20 | 1.08 | 33.77 | 0.3356 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.43bn | 523.43m | 13.26bn | 8.41k | 25.54 | 1.86 | -- | 2.06 | 0.202 | 0.202 | 2.49 | 2.78 | 0.5568 | 2.39 | 4.60 | 764,058.90 | 5.02 | 6.77 | 7.25 | 10.50 | 54.36 | 63.24 | 9.02 | 11.10 | 1.53 | 40.71 | 0.1459 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.25bn | 989.32m | 13.46bn | 4.88k | 13.56 | 1.54 | -- | 2.56 | 1.10 | 1.10 | 5.84 | 9.69 | 0.4523 | 1.87 | 4.36 | 1,076,055.00 | 8.52 | 10.10 | 11.07 | 13.69 | 35.80 | 34.64 | 18.83 | 16.26 | 2.07 | -- | 0.1816 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.07bn | 352.22m | 13.47bn | 965.00 | 38.25 | 2.70 | -- | 12.55 | 0.571 | 0.571 | 1.74 | 8.09 | 0.2078 | 1.14 | 9.25 | 1,112,527.00 | 6.61 | 1.32 | 6.93 | 1.41 | 77.85 | 80.74 | 31.81 | 6.55 | 6.66 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 14.03bn | 3.36k | 705.38 | 0.4809 | -- | 1.26 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
| Anhui Huaheng Biotechnology Co Ltd | 2.04bn | 454.44m | 14.20bn | 1.69k | 31.27 | 7.42 | -- | 6.96 | 2.88 | 2.88 | 12.94 | 12.15 | 0.6196 | 5.59 | 8.04 | 1,205,674.00 | 13.71 | 16.74 | 21.59 | 22.41 | 38.49 | 39.21 | 22.13 | 22.34 | 0.4552 | 155.98 | 0.4552 | 25.20 | 36.63 | 35.72 | 40.32 | 42.84 | 82.09 | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.43bn | 614.24m | 14.23bn | 2.53k | 23.02 | 4.82 | -- | 4.15 | 1.09 | 1.09 | 6.09 | 5.21 | 0.7246 | 2.04 | 13.84 | 1,356,471.00 | 12.97 | 10.68 | 21.27 | 16.56 | 71.74 | 74.42 | 17.90 | 14.92 | 1.26 | -- | 0.0122 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| KPC Pharmaceuticals Inc | 7.65bn | 432.35m | 14.60bn | 5.05k | 33.70 | 2.70 | -- | 1.91 | 0.5725 | 0.5725 | 10.15 | 7.15 | 0.8021 | 2.48 | 2.62 | 1,513,702.00 | 4.63 | 5.42 | 7.76 | 9.13 | 43.12 | 43.68 | 5.77 | 5.70 | 1.46 | 53.93 | 0.1688 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.78bn | 843.91m | 14.66bn | 11.61k | 17.09 | 1.15 | -- | 1.24 | 0.6394 | 0.6394 | 8.95 | 9.48 | 0.6069 | 3.08 | 6.61 | 1,014,487.00 | 5.75 | 4.85 | 8.50 | 8.17 | 37.09 | 43.00 | 9.48 | 7.03 | 1.82 | -- | 0.1057 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| BrightGene Bio-Medical Technology Co Ltd | 1.21bn | 195.77m | 14.75bn | 1.16k | 76.41 | 6.08 | -- | 12.14 | 0.4569 | 0.4569 | 2.87 | 5.75 | 0.2463 | 1.69 | 4.43 | 1,051,700.00 | 3.43 | 6.53 | 4.29 | 7.93 | 54.92 | 56.93 | 13.93 | 19.90 | 1.45 | 4.86 | 0.4787 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
Data as of Jun 18 2024. Currency figures normalised to Sunshine Guojian Pharmaceutical Shanghai Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
21.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 4.76m | 5.13% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 3.88m | 4.18% |
| Fullgoal Fund Management Co., Ltd.as of 30 Sep 2023 | 2.68m | 2.89% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Sep 2023 | 2.14m | 2.31% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 1.36m | 1.47% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023 | 1.23m | 1.33% |
| Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 1.04m | 1.12% |
| AXA-SPDB Investment Managers Co., Ltd.as of 30 Sep 2023 | 865.06k | 0.93% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Sep 2023 | 835.18k | 0.90% |
| ABC-CA Fund Management Co., Ltd.as of 30 Sep 2023 | 780.43k | 0.84% |
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
